Preventing chronic bleeding from the brain’s covering after surgery
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial looks at whether a procedure called middle meningeal artery embolization can help stop chronic subdural hematoma (slow bleeding/collection under the brain covering) from coming back after your first surgery. It studies an added endovascular treatment right after your operation to reduce recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older
- You previously had surgery for your first chronic subdural hematoma using one or more burr holes (not a larger opening)
- Your brain scan (CT or MRI) showed the chronic subdural hematoma at the time of that first surgery
- You can agree to both the surgery and the additional endovascular procedure, and you can follow study instructions
- After surgery, angiography (a special X-ray of blood vessels) can be done within 72 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests a procedure that blocks blood flow to the membrane around the brain to treat a chronic subdural hematoma (a slow buildup of blood pressing on the brain). It may help avoid surgery and reduce symptoms like headaches, confusion, or weakness.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This trial tests a minimally invasive procedure to treat chronic subdural hematoma (a slow bleed on the brain). It aims to stop the bleeding and reduce the risk of needing surgery.
This study tracks patients who get a procedure called middle meningeal artery embolization (a treatment that blocks blood flow to the lining of the brain to help a chronic subdural hematoma heal). The goal is to see how well it works and how patients recover over time.
Hear when a new Hematoma, Subdural, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.